These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 67714)

  • 21. In vivo behaviour of gamma globulin preparations.
    Morell A; Schürch B; Ryser D; Hofer F; Skvaril F; Barandun S
    Vox Sang; 1980; 38(5):272-83. PubMed ID: 6158170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [THERAPY OF TETANUS WITH THE USE OF HUMAN TETANUS ANTITOXIN IN THE FORM OF GAMMA GLOBULIN (TETANUS HYPERIMMUNE GLOBULIN)].
    VOSS R; SCHOEN HR; KOERNER L; LALLEMAND H; GRABOW L
    Munch Med Wochenschr; 1965 Apr; 107():854-7. PubMed ID: 14306952
    [No Abstract]   [Full Text] [Related]  

  • 23. Conventional immunoglobulin therapy.
    Hitzig WH; Müntener U
    Birth Defects Orig Artic Ser; 1975; 11(1):339-42. PubMed ID: 50096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adequate dosage of tetanus antitoxin and tetanus-immune human gamma globulin TIG in the treatment of tetanus].
    Ebisawa I
    Masui; 1974 May; 23(5):381-7. PubMed ID: 4137369
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunologic properties, aggregate content and half-life of various human i.v. gamma globulin preparations].
    Ring J; Duswald KH; Seifert J; Brendel W
    Langenbecks Arch Chir; 1976; Suppl():63-7. PubMed ID: 73997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BIOLOGICAL ACTIVITIES OF AGGREGATED GAMMA-GLOBULIN. VII. MINIMUM SIZE OF AGGREGATED GAMMA-GLOBULIN OR ITS PIECE 3 REQUIRED FOR THE INDUCTION OF SKIN REACTIVITY AND COMPLEMENT FIXATION.
    ISHIZAKA K; ISHIZAKA T; BANOVITZ J
    J Immunol; 1965 Jun; 94():825-32. PubMed ID: 14321425
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new immune serum globulin preparation for intravenous administration (author's transl)].
    Mozen MM; Schroeder DD; Cabasso VJ
    Arzneimittelforschung; 1980; 30(9):1484-6. PubMed ID: 7193013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preparation of gamma-globulin for intravenous use in Paris.
    Steinbuch M; Audran R; Amouch P; Blatrix C
    Vox Sang; 1967 Jul; 13(1):103-6. PubMed ID: 4166587
    [No Abstract]   [Full Text] [Related]  

  • 29. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of human gamma-globulin preparations against experimental aerosol infections of mice with Bordetella pertussis.
    Imaizumi A; Suzuki Y; Sato H; Sato Y
    Vox Sang; 1985; 48(1):18-25. PubMed ID: 2578698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of congenital agammaglobulinaemia by intravenous gammaglobulin with Fc activities.
    Miyazaki S; Shibata R; Kishida K; Goya N
    Lancet; 1978 Feb; 1(8058):283. PubMed ID: 74712
    [No Abstract]   [Full Text] [Related]  

  • 32. Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.
    Lin CY; Hsu HC; Chiang H
    Nephron; 1989; 53(4):303-10. PubMed ID: 2481240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioether-bonded constructs of Fab'gamma and Fc gamma modules utilizing differential reduction of interchain disulfide bonds.
    Kan KS; Anderson VA; Leong WS; Smith AM; Worth AT; Stevenson GT
    J Immunol; 2001 Jan; 166(2):1320-6. PubMed ID: 11145716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lyophilized anti-D gamma globulin given intravenously for the prevention of anti-Rh immunization].
    Jouvenceaux A; Adenot N; Berthoux F; Revol L
    Rev Fr Transfus; 1969; 12(1):Suppl:341-7. PubMed ID: 4193519
    [No Abstract]   [Full Text] [Related]  

  • 35. BIOLOGIC ACTIVITIES OF AGGREGATED GAMMA-GLOBULIN. VI. AGGREGATED PRODUCTS OF RABBIT SERUM PROTEINS.
    SUGAHARA T; ISHIZAKA K; ISHIZAKA T
    J Immunol; 1963 Jun; 90():960-70. PubMed ID: 14050207
    [No Abstract]   [Full Text] [Related]  

  • 36. Active-passive immunization of human subjects against tetanus using homologous gamma globulin.
    Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological activities of aggregated gamma globulin. I. Skin reactive and complement-fixing properties of heat denatured gamma globulin.
    ISHIZAKA T; ISHIZAKA K
    Proc Soc Exp Biol Med; 1959; 101():845-50. PubMed ID: 14405924
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.
    Theofilopoulos AN; Wilson CB; Bokisch VA; Dixon FJ
    J Exp Med; 1974 Nov; 140(5):1230-44. PubMed ID: 4138539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HUMAN HYPERIMMUNE GLOBULIN IN TETANUS. REPORT OF A CASE.
    PAGANDERODRIGUEZ J; MUNOZ AI
    Bol Asoc Med P R; 1965 Jun; 57():303-5. PubMed ID: 14330346
    [No Abstract]   [Full Text] [Related]  

  • 40. Tetanus; the use of human hyperimmune globulin in treatment.
    NATION NS; PIERCE NF; ADLER SJ; CHINNOCK RF; WEHRLE PF
    Calif Med; 1963 Jun; 98(6):305-7. PubMed ID: 13937706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.